Literature DB >> 10448974

Diagnostic dilemmas in amyotrophic lateral sclerosis.

B R Brooks1.   

Abstract

The El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis (ALS) were introduced in 1990 to provide a standardised and diagnostically reliable approach to the early recognition of this disease. It is still unclear, however, whether these are the best criteria available for the early diagnosis of ALS. We applied these criteria retrospectively to clinical material available from 34 cases of autopsy proven ALS in an attempt to validate their usefulness in a pathological series. The clinical material was reviewed and specific clinical signs and anatomical levels of involvement recorded. Only signs listed in the criteria were included in the analysis. The El Escorial criteria for clinically definite ALS demonstrated high sensitivity and accuracy when validated in this clinicopathological study. Neuroimaging and electromyography were important in shortening the time in which patients were given a diagnosis of clinically definite ALS. Other diagnostic dilemmas in ALS and the role of early diagnosis of this disease are discussed.

Entities:  

Mesh:

Year:  1999        PMID: 10448974     DOI: 10.1016/s0022-510x(99)00019-2

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Motor neuron degeneration promotes neural progenitor cell proliferation, migration, and neurogenesis in the spinal cords of amyotrophic lateral sclerosis mice.

Authors:  Liying Chi; Yan Ke; Chun Luo; Baolin Li; David Gozal; Balaraman Kalyanaraman; Rugao Liu
Journal:  Stem Cells       Date:  2005-08-11       Impact factor: 6.277

2.  Detection of corticospinal tract compromise in amyotrophic lateral sclerosis with brain MR imaging: relevance of the T1-weighted spin-echo magnetization transfer contrast sequence.

Authors:  Antônio J da Rocha; Acary S B Oliveira; Ricardo B Fonseca; Antônio C M Maia; Renata P Buainain; Henrique M Lederman
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

3.  Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis.

Authors:  Srikanth Ranganathan; Eric Williams; Philip Ganchev; Vanathi Gopalakrishnan; David Lacomis; Leo Urbinelli; Kristyn Newhall; Merit E Cudkowicz; Robert H Brown; Robert Bowser
Journal:  J Neurochem       Date:  2005-12       Impact factor: 5.372

4.  Diagnostic accuracy using diffusion tensor imaging in the diagnosis of ALS: a meta-analysis.

Authors:  Bradley R Foerster; Ben A Dwamena; Myria Petrou; Ruth C Carlos; Brian C Callaghan; Martin G Pomper
Journal:  Acad Radiol       Date:  2012-06-28       Impact factor: 3.173

5.  Brain Parenchymal Fraction: A Relatively Simple MRI Measure to Clinically Distinguish ALS Phenotypes.

Authors:  Venkateswaran Rajagopalan; Erik P Pioro
Journal:  Biomed Res Int       Date:  2015-12-13       Impact factor: 3.411

6.  Minimizing the Diagnostic Delay in Amyotrophic Lateral Sclerosis: The Role of Nonneurologist Practitioners.

Authors:  Martin Matharan; Stéphane Mathis; Sarah Bonabaud; Louis Carla; Antoine Soulages; Gwendal Le Masson
Journal:  Neurol Res Int       Date:  2020-05-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.